These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 29321348

  • 21. PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity.
    Stocco G, Yang W, Crews KR, Thierfelder WE, Decorti G, Londero M, Franca R, Rabusin M, Valsecchi MG, Pei D, Cheng C, Paugh SW, Ramsey LB, Diouf B, McCorkle JR, Jones TS, Pui CH, Relling MV, Evans WE.
    Hum Mol Genet; 2012 Nov 01; 21(21):4793-804. PubMed ID: 22846425
    [Abstract] [Full Text] [Related]

  • 22. Association Between Combined Presence of Hepatitis C Virus and Polymorphisms in Different Genes With Toxicities of Methotrexate and 6-Mercaptopurine in Children With Acute Lymphoblastic Leukemia.
    Abdelaziz DH, Elhosseiny NM, Khaleel SA, Sabry NA, Attia AS, El-Sayed MH.
    Pediatr Blood Cancer; 2016 Sep 01; 63(9):1539-45. PubMed ID: 27163515
    [Abstract] [Full Text] [Related]

  • 23. [Correlations between 6-mercaptopurine treatment-related adverse reactions in children with acute lymphoblastic leukemia and polymorphisms of thiopurine methyltransferase gene].
    Xie C, Yue LJ, Ding H, Ren YF, Yang CL, Zheng MM.
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 May 01; 16(5):499-503. PubMed ID: 24857000
    [Abstract] [Full Text] [Related]

  • 24. Analysis of Thiopurine S-Methyltransferase Deficient Alleles in Acute Lymphoblastic Leukemia Patients in Mexican Patients.
    Jiménez-Morales S, Ramírez-Florencio M, Mejía-Aranguré JM, Núñez-Enríquez JC, Bekker-Mendez C, Torres-Escalante JL, Flores-Lujano J, Jiménez-Hernández E, Del Carmen Rodríguez-Zepeda M, Leal YA, González-Montalvo PM, Pantoja-Guillen F, Peñaloza-Gonzalez JG, Gutiérrez-Juárez EI, Núñez-Villegas NN, Pérez-Saldivar ML, Guerra-Castillo FX, Flores-Villegas LV, Ramos-Cervantes MT, Fragoso JM, García-Escalante MG, Del Carmen Pinto-Escalante D, Ramírez-Bello J, Hidalgo-Miranda A.
    Arch Med Res; 2016 Nov 01; 47(8):615-622. PubMed ID: 28476189
    [Abstract] [Full Text] [Related]

  • 25. Thiopurine drugs in the treatment of childhood leukaemia: the influence of inherited thiopurine methyltransferase activity on drug metabolism and cytotoxicity.
    Lennard L, Welch JC, Lilleyman JS.
    Br J Clin Pharmacol; 1997 Nov 01; 44(5):455-61. PubMed ID: 9384462
    [Abstract] [Full Text] [Related]

  • 26. Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia.
    McLeod HL, Krynetski EY, Relling MV, Evans WE.
    Leukemia; 2000 Apr 01; 14(4):567-72. PubMed ID: 10764140
    [Abstract] [Full Text] [Related]

  • 27. Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report from the Children's Cancer Group.
    Nachman J, Sather HN, Gaynon PS, Lukens JN, Wolff L, Trigg ME.
    J Clin Oncol; 1997 Jun 01; 15(6):2222-30. PubMed ID: 9196134
    [Abstract] [Full Text] [Related]

  • 28. Human granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia: a Children's Cancer Group Study.
    Heath JA, Steinherz PG, Altman A, Sather H, Jhanwar S, Halpern S, Pieters R, Shah N, Steinherz L, Tannous R, Terry W, Trigg ME, Children's Cancer Group.
    J Clin Oncol; 2003 Apr 15; 21(8):1612-7. PubMed ID: 12697887
    [Abstract] [Full Text] [Related]

  • 29. Analysis of thiopurine methyltransferase variant alleles in childhood acute lymphoblastic leukaemia.
    McLeod HL, Coulthard S, Thomas AE, Pritchard SC, King DJ, Richards SM, Eden OB, Hall AG, Gibson BE.
    Br J Haematol; 1999 Jun 15; 105(3):696-700. PubMed ID: 10354134
    [Abstract] [Full Text] [Related]

  • 30. Thiopurine dose intensity and treatment outcome in childhood lymphoblastic leukaemia: the influence of thiopurine methyltransferase pharmacogenetics.
    Lennard L, Cartwright CS, Wade R, Vora A.
    Br J Haematol; 2015 Apr 15; 169(2):228-40. PubMed ID: 25441457
    [Abstract] [Full Text] [Related]

  • 31. Novel variant in Nudix hydrolase 15 gene influences 6-mercaptopurine toxicity in childhood acute lymphoblastic leukemia patients.
    Sabirova Z, Mahnoor S, Lasfar D, Gagné V, Théorêt Y, Leclerc JM, Laverdière C, Sinnett D, Tran TH, Krajinovic M.
    Pharmacogenet Genomics; 2024 Jul 01; 34(5):170-173. PubMed ID: 38682355
    [Abstract] [Full Text] [Related]

  • 32. The low frequency of defective TPMT alleles in Turkish population: a study on pediatric patients with acute lymphoblastic leukemia.
    Tumer TB, Ulusoy G, Adali O, Sahin G, Gozdasoglu S, Arinç E.
    Am J Hematol; 2007 Oct 01; 82(10):906-10. PubMed ID: 17617792
    [Abstract] [Full Text] [Related]

  • 33. Neurodevelopmental outcome of infants with acute lymphoblastic leukemia: a Children's Cancer Group report.
    Kaleita TA, Reaman GH, MacLean WE, Sather HN, Whitt JK.
    Cancer; 1999 Apr 15; 85(8):1859-65. PubMed ID: 10223582
    [Abstract] [Full Text] [Related]

  • 34. Pharmacogenetics of 6-mercaptopurine in a black Zimbabwean cohort treated for acute lymphoblastic leukaemia.
    Chikondowa P, Munkombwe D, Chikwambi Z, Kuona P, Masimirembwa C.
    Pharmacogenomics; 2023 Jun 15; 24(8):449-457. PubMed ID: 37248698
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The Role of TPMT, ITPA, and NUDT15 Variants during Mercaptopurine Treatment of Swedish Pediatric Patients with Acute Lymphoblastic Leukemia.
    Wahlund M, Nilsson A, Kahlin AZ, Broliden K, Myrberg IH, Appell ML, Berggren A.
    J Pediatr; 2020 Jan 15; 216():150-157.e1. PubMed ID: 31635813
    [Abstract] [Full Text] [Related]

  • 37. Prognostic impact of IKZF1 deletions in association with vincristine-dexamethasone pulses during maintenance treatment of childhood acute lymphoblastic leukemia on trial ALL-BFM 95.
    Hinze L, Möricke A, Zimmermann M, Junk S, Cario G, Dagdan E, Kratz CP, Conter V, Schrappe M, Stanulla M.
    Leukemia; 2017 Aug 15; 31(8):1840-1842. PubMed ID: 28529312
    [No Abstract] [Full Text] [Related]

  • 38. Prevalence of TPMT, ITPA and NUDT 15 genetic polymorphisms and their relation to 6MP toxicity in north Indian children with acute lymphoblastic leukemia.
    Khera S, Trehan A, Bhatia P, Singh M, Bansal D, Varma N.
    Cancer Chemother Pharmacol; 2019 Feb 15; 83(2):341-348. PubMed ID: 30474703
    [Abstract] [Full Text] [Related]

  • 39. Pharmacokinetics, dose adjustments, and 6-mercaptopurine/methotrexate drug interactions in two patients with thiopurine methyltransferase deficiency.
    Andersen JB, Szumlanski C, Weinshilboum RM, Schmiegelow K.
    Acta Paediatr; 1998 Jan 15; 87(1):108-11. PubMed ID: 9510461
    [Abstract] [Full Text] [Related]

  • 40. Thiopurine Methyltransferase Intermediate Metabolizer Status and Thiopurine-Associated Toxicity During Maintenance Therapy in Childhood Acute Lymphoblastic Leukemia.
    Schwarz UI, Woldanski-Travaglini M, Swanston V, Mikhail M, Cacciotti C, Cairney E, Patel S, Seelisch J, Tole S, Wilejto M, Tirona RG, Kim RB, Zorzi AP.
    Clin Pharmacol Ther; 2023 Jun 15; 113(6):1326-1336. PubMed ID: 36932910
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.